학술논문
GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease
Document Type
Article
Author
Source
In Cancer Letters 28 June 2016 376(1):104-109
Subject
Language
ISSN
0304-3835